
Keywords: انتگرال β3; SNP; single nucleotide polymorphism; VTE; venous thromboembolism; CRC; colorectal cancer; RFLP; restriction fragment length polymorphism; Single nucleotide polymorphism; Integrin β3; Venous thromboembolism risk; Colorectal cancer; rs3809565; Anticoagulan